[김창수의 e뉴스 브리핑] Chong Kun Dang’Napa Beltan’ applied for conditional permission for corona treatment, etc.

[FETV=김창수 기자] On the 8th, Chong Kun Dang applied for conditional approval and phase 3 clinical approval of’Napabeltan (ingredient name Napamostat)’ as a COVID-19 treatment for severely high-risk patients with the Ministry of Food and Drug Safety. Daewoong Pharmaceutical announced on the 8th that it is recruiting organizations to donate a set of picture books to help slow learners communicate disease expressions. The picture book set that will be distributed in Daewoong Pharmaceutical’s social contribution program’Do not take part’ is designed to more effectively use AAC (complementary and alternative communication cards) that have already been distributed through e-books and offline. Kwangdong Pharmaceutical announced on the 8th that it showed off the Vita 500 CF to support tired people with’Jenny’, a black pink member with a refreshing and youthful image.

◆ Chong Kun Dang’s’Napa Beltan’ applied for conditional permission for corona treatment

On the 8th, Chong Kun Dang applied for conditional approval and phase 3 clinical approval of’Napabeltan (ingredient name Napamostat)’ as a COVID-19 treatment for severely high-risk patients to the Ministry of Food and Drug Safety (Ministry of Food and Drug Safety).

Chong Kun Dang conducted phase 2 clinical trials in 104 severely ill patients with Corona 19 in Russia last year, demonstrating that Napabeltan prevents worsening of symptoms in severely high-risk patients caused by Corona 19, and significantly improves treatment duration and treatment rate. In particular, it is expected that treatment mechanisms will be applied to the mutations of viruses found abroad, so that it will be able to actively respond to the spread of various mutant viruses.

◆ Daewoong Pharmaceutical, “Find an institution that needs’picture books for slow learners’”

Daewoong Pharmaceutical announced on the 8th that it is recruiting organizations to donate a set of picture books to help slow learners communicate disease expressions.

The picture book set to be distributed this time in Daewoong Pharmaceutical’s representative social contribution program’Do not take part’ can more effectively use the AAC (Augmentative and Alternative Communication Card) that has already been distributed through e-books and offline. It was made to be.

It is composed of episodes with easy expressions and intuitive illustrations so that slow learners with developmental disabilities or borderline intelligence can clearly grasp each disease symptom and feel interest. The AAC produced by Cham Do Not Mayo can also be found as an e-book on Cham Do Not Mayo’s official website.

◆”Black Pink Jenny’s Choice” Kwangdong Pharmaceutical Unveils Vita 500 New CF

Kwangdong Pharmaceutical announced on the 8th that it showed off the Vita 500 CF to support tired people with’Jenny’, a black pink member with a refreshing and youthful image.

This CF shows that vitamin C, the main ingredient of Vita 500, helps refresh your daily life with a healthy and happy life. The company announced that it has chosen Jenny as a model to restore vitality and laughter to those who have been tired of long social distancing and diminished daily life.

In the commercial video that starts with a clear sky in the background, Jenny showed off her fresh and youthful charm by freely moving between a bright smile and a serious expression. Through this, it expresses the message of refreshing the difficult daily life with the Vita 500 and starting anew again.

◆ GC Green Cross Well-being, dark cachexia drug’GCWB204′ confirmed the effect of inhibiting muscle atrophy

GC Green Cross Wellbeing announced on the 8th that the research results of its new dark cachexia drug’GCWB204′ were recently published in the SCI-level international academic journal’International Journal of Environmental Research and Public Health’.

This paper is about the inhibitory effect and mechanism of GCWB204’s muscle atrophy, and was jointly participated by Professor Gyuwoon Bae and the GC Green Cross Well-being Research Team at Sookmyung Women’s University College of Pharmacy.

The study was conducted in a muscle atrophy cell model induced by’dexamethasone’, which belongs to a steroid-based synthetic hormone. As a result of the study, it was confirmed that the expression of the’Myosin heavy chain (MHC)’, a muscle atrophy protein reduced by decamethasone, was normalized in cells treated with’GCWB204′. In addition, it was found that’GCWB204′ increased the expression of’PGC1α’, an intracellular energy metabolism regulator, by about 37% compared to the placebo group, thereby promoting the generation of energy sources necessary for muscle cells.

◆ ID Dental Clinic Director Yang-gu Lee “Moving to the front and back of the tooth is possible through the Inbijeol line”

Lee Yang-gu, the director of ID Dental Clinic, who specializes in orthodontics, said that it is possible to move the teeth back and forth through the inbijeol line braces, so that the same treatment as existing braces can be expected.

According to ID Dental Clinic on the 8th, Director Yang-gu Lee participated as a speaker at the Inviserline Korea ‘4人4色 Inbijeolline Concert’ held through a webinar on the 7th. Inbijeolline is a type of transparent braces, and is a highly complete detachable product by manufacturing and procuring dental braces directly from Align Technology, an American manufacturer.

Director Lee said, “As a result of treating various patients with the invisible line correction, we were able to obtain results that the teeth can be moved back and forth.” “Although the usage with other braces is slightly different, the existing braces and the invisible line can produce similar effects. There is” insisted.